Vital Signs - Impact of 'Intended Use' On New Diagnostics
Vital Signs - Impact of 'Intended Use' On New Diagnostics
RELEASE DATE
22-Dec-2008
22-Dec-2008
REGION
North America
North America
Research Code: 9561-00-7E-00-00
SKU: HC00557-NA-MR_04029
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00557-NA-MR_04029
Description
This issue of Vital Signs, released on December 22, 2008, provides an strategic overview of the impact of intended use on new clinical diagnostics. Additionally, a company spotlight is provided for InfraReDx, an emerging medical diagnostics company. Reimbursement and regulatory news from the FDA is also provided for the week of December 8, 2008.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on December 22, 2008, provides an strategic overview of the impact of intended use on new clinical diagnostics. Additionally, a company spotlight is provided for InfraReDx, an emerging medical diagnostics company. Reimbursement and regulatory news from the FDA is also provided for the week of December 8, 2008.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-7E-00-00 |
Is Prebook | No |